NCT05234723

Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients

RecruitingOBSERVATIONAL

Trial Details

Start: 2023-06-19Est. Completion: 2027-02-28

Enrollment target: 100 participants

Locations

MD Anderson Cancer Center, Houston, Texas, United States
Institut Jules Bordet, Brussels, Belgium
University Hospitals Leuven, Leuven, Belgium
Helsinki University Central Hospital, Helsinki, Helsinki, Finland
Centre Hospitalier Universitaire de Limoges, Limoges, Limoges, France
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Bologna, Italy
Humanitas Research Hospital, Rozzano, Milano, Italy
Istituto mediterraneo per i trapianti e terapie ad alta specializzazione (ISMETT), Palermo, Palermo, Italy
Ospedale San Martino, Genova, Italy
Policlinico di Milano, Milan, Italy
Azienda Ospedaliero-Universitaria di Modena, Modena, Italy
Azienda Ospedaliera dei Colli, Naples, Italy
Azienda Ospedale-Università Padova, Padova, Italy
AOU Città della salute e della scienza, Torino, Italy
ASST dei Sette Laghi, Varese, Italy
São João University Hospital, Porto, Portugal
Hospital Clinic, Barcelona, Spain
Instituto Maimónides de Investigación Biomédica de Córdoba, Córdoba, Spain

EBVHSVVZVHPVCMV

Background: * Infections caused by viruses are common causes of illnesses: the common cold, many ear infections, sore t…

Bethesda, United States

Cytomegalovirus (CMV)Inflammatory Bowel Disease (IBD)

Observational, single-center, non-pharmacological, prospective study of adult patients affected by Inflammatory Bowel Di…

Bologna, ItalyEst. completion Dec 31, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.